Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs

被引:66
|
作者
Beloqui, Ana [1 ]
del Pozo-Rodriguez, Ana [2 ]
Isla, Arantxazu [2 ]
Rodriguez-Gascon, Alicia [2 ]
Angeles Solinis, Maria [2 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, Belgium
[2] Univ Basque Country, Pharmacokinet Nanotechnol & Gene Therapy Grp Phar, Fac Pharm, UPV EHU,Lascaray Res Ctr, Paseo Univ 7, Vitoria 01006, Spain
关键词
Nanostructured lipid carriers; Poor water soluble drugs; Oral drug delivery; Bioavailability; Hot high-pressure homogenization; Inflammatory bowel diseases; OF-THE-ART; BIOAVAILABILITY ENHANCEMENT; IN-VIVO; PHYSICOCHEMICAL CHARACTERIZATION; FORMULATION DEVELOPMENT; GASTROINTESTINAL MUCUS; INTESTINAL BARRIER; NANOPARTICLES SLN; LIPOPHILIC DRUGS; PHARMACOKINETICS;
D O I
10.1016/j.jddst.2017.06.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poorly water soluble (PWS) drugs lack from good oral absorption, which limits their oral administration, the most common drug delivery route. The design of appropriate innovative formulations for PWS drugs will allow for adequate bioavailability, reduction of the required dose and oral delivery of drugs that would otherwise need the parenteral route. Among the formulations under study, Nanostructured Lipid Carriers (NLCs), made of biocompatible mixtures of solid and liquid lipids, represent a good choice. NLCs enhance the apparent solubility and dissolution of PWS drugs in the gastrointestinal tract, and/or modulate the drug permeability and fate across the intestinal barrier, opening new perspectives in the field of innovative medicines for oral administration of PWS molecules. Recently, NLCs have also emerged as a promising anti-inflammatory drug delivery system for inflammatory bowel diseases. The present paper is focused on the state of the art of NLCs for oral delivery of PWS drugs. The design, the main preparation techniques and the mechanisms through the drug oral delivery is improved by NLCs are presented, highlighting the influence of the most relevant technological and formulation factors on the properties of the NLCs, which condition their efficacy as oral delivery formulations. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 50 条
  • [1] Potential of nanostructured lipid carriers in oral delivery of the poorly soluble drugs
    Jiwankar, Manasi
    Sabale, Vidya
    JOURNAL OF NANOPARTICLE RESEARCH, 2023, 25 (09)
  • [2] Potential of nanostructured lipid carriers in oral delivery of the poorly soluble drugs
    Manasi Jiwankar
    Vidya Sabale
    Journal of Nanoparticle Research, 2023, 25
  • [3] Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs
    Choi, Kyeong-Ok
    Choe, Jaehyeog
    Suh, Seokjin
    Ko, Sanghoon
    MOLECULES, 2016, 21 (05):
  • [4] New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs
    Muellertz, Anette
    Ogbonna, Anayo
    Ren, Shan
    Rades, Thomas
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (11) : 1622 - 1636
  • [5] Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin
    Liu, Ying
    Wang, Lan
    Zhao, Yiqing
    He, Man
    Zhang, Xin
    Niu, Mengmeng
    Feng, Nianping
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 476 (1-2) : 169 - 177
  • [6] Lipid-based vehicles for the oral delivery of poorly water soluble drugs
    Humberstone, AJ
    Charman, WN
    ADVANCED DRUG DELIVERY REVIEWS, 1997, 25 (01) : 103 - 128
  • [7] Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update
    Ma X.
    Williams R.O., III
    Journal of Pharmaceutical Investigation, 2018, 48 (1) : 61 - 75
  • [8] Nanostructured Lipid Carriers- A Versatile Carrier for Oral Delivery of Lipophilic Drugs
    Patel, Priyanshi
    Patel, Mitali
    RECENT PATENTS ON NANOTECHNOLOGY, 2021, 15 (02) : 154 - 164
  • [9] Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use
    Nerli, Giulia
    Goncalves, Lidia M. D.
    Cirri, Marzia
    Almeida, Antonio J.
    Maestrelli, Francesca
    Mennini, Natascia
    Mura, Paola A.
    PHARMACEUTICS, 2023, 15 (04)
  • [10] Lipid-based systems for the enhanced delivery of poorly water soluble drugs
    Porter, Christopher J. H.
    Wasan, Kishor M.
    ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (06) : 615 - 616